Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine

Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine

US Patent 9896411 · Granted Feb 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ready-to-use, terminally sterile packaging for surgical antiseptic and method of2025
Platform drug delivery system utilizing crystal engineering and theanine dissolu2025
Platform drug delivery system utilizing crystal engineering and theanine dissolu2025
Amorphous onapristone compositions and methods of making the same2020
Characterization of the cocrystal products formed by metoprolol and dabigatran b2019
Characterization of the cocrystal products formed by metoprolol and dabigatran b2019
Polymorphic forms of naltrexone2019
Polymorphic forms of naltrexone2019
Polymorphic forms of naltrexone2018
Polymorphic forms of naltrexone2017
Platform drug delivery system utilizing crystal engineering and theanine dissolu2017
Platform drug delivery system utilizing crystal engineering and theanine dissolu2017